Pharmaceutical Care Issues of Patients with Rheumatoid Arthritis

Author: Louise Grech
Publisher: Springer
ISBN: 9811014213
Format: PDF
Download Now
This book presents concise, comprehensive summaries of topics necessary to understand rheumatoid arthritis (RA) management, aligned with patient needs, as a reference suitable for practitioners and students of all levels. Special attention is paid to the innovative RhMAT (Rheumatoid Arthritis Medication Assessment Tool), in addition to descriptions of the pharmacological management of RA, pharmacoeconomic and pharmacovigilance considerations, the benefits of seamless care, and case presentations.Rheumatoid arthritis is one of the most common forms of inflammatory arthritis in the world, with a prevalence of 0.5 to 1%. While no cure has yet been established, modern biotechnology has enabled highly effective management, if treatment begins early. However, cost and side effects, such as immune suppression, continue to present barriers, and monitoring of patients is pivotal to safe and effective disease management. Both hospital and community pharmacists are involved in RA patient management, and have responsibilities to this patient population. Identifying pharmaceutical care issues and ensuring that the patients are managed in accordance to best evidence-based medicine are paramount. Best care is delivered when pharmacists effectively communicate with each other, the prescribers and the multidisciplinary team members involved in the care of the patient. This book aims to tackle the various aspects of the management of RA patients across all the settings.

Regulating Pharmaceuticals In Europe Striving For Efficiency Equity And Quality

Author: Mossialos, Elias
Publisher: McGraw-Hill Education (UK)
ISBN: 0335226558
Format: PDF, Kindle
Download Now
The rising cost of pharmaceutical expenditures in many European countries is of concern to governments required to make effective use of health care budgets. Taking a broad perspective that encompasses institutional, political and supranational aspects of pharmaceutical regulation, this book examines approaches used to manage pharmaceutical expenditure across Europe and what impact these strategies have had on efficiency, quality, equity and cost of pharmaceutical care. Regulating Pharmaceuticals in Europe is an important book for students of health policy, regulation and management, and for health managers and policy makers.

Building a Successful Ambulatory Care Practice

Author: Mary Ann Kliethermes
Publisher: ASHP
ISBN: 9781585283491
Format: PDF, ePub, Mobi
Download Now
Let ASHP’s new book be your blueprint to a thriving ambulatory care practice, whether it’s health-system, physician, or community based. Get comprehensive, practical guidance on all your questions. Topics include: • How do I write a business plan? • What do I need to do to manage risk and liability? • Why do we need a marketing strategy? • Who handles reimbursements? • What credentials do we need? Plus: A companion web toolkit gives you all the help and templates you need to get going.

Oxford Handbook of Clinical Pharmacy

Author: Philip Wiffen
Publisher: Oxford University Press
ISBN: 0191054704
Format: PDF
Download Now
Complementing the guidelines in the British National Formulary, the third edition of the Oxford Handbook of Clinical Pharmacy remains the indispensable guide to clinical pharmacy, providing all the information needed for practising and student pharmacists. It presents handy practical guidance in a quick-reference, bullet-point format to give the reader the knowledge and confidence needed to provide a clinical pharmacy service. Including key information on controlled drugs, adverse drug reactions, interactions, communication skills, and confidentiality, this extensively revised addition to the bestselling Oxford Handbook series is the fundamental pharmacy reference tool. It features chapters on adherence, anaphylaxis, clinical trials, herbal medicines, palliative care, patient management, pharmaceutical calculations, research, policy, and therapy related issues. Thoroughly revised and updated, the Oxford Handbook of Clinical Pharmacy includes brand new topics, including content on health coaching, residency and on-call, HIV and TB and mental health.

Changing Health Care Systems and Rheumatic Disease

Author: Committee on Changing Health Care Systems and Rheumatic Disease
Publisher: National Academies
ISBN:
Format: PDF, ePub
Download Now
Market forces are driving a radical restructuring of health care delivery in the United States. At the same time, more and more people are living comparatively long lives with a variety of severe chronic health conditions. Many such people are concerned about the trend toward the creation of managed care systems because their need for frequent, often complex, medical services conflicts with managed care's desires to contain costs. The fear is that people with serious chronic disorders will be excluded from or underserved by the integrated health care delivery networks now emerging. Responding to a request from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, this book reflects the results of a workshop that focused on the following questions: Does the model of managed care or an integrated delivery system influence the types of interventions provided to patients with chronic conditions and the clinical and health status outcomes resulting from those interventions? If so, are these effects quantitatively and clinically significant, as compared to the effects that other variables (e.g., income, education, ethnicity) have on patient outcomes? If the type of health care delivery system appears to be related to patient care and outcomes, can specific organizational, financial, or other variables be identified that account for the relationships? If not, what type of research should be pursued to provide the information needed about the relationship between types of health care systems and the processes and outcomes of care provided to people with serious chronic conditions?

Services for People With Rheumatoid Arthritis

Author: Great Britain: National Audit Office
Publisher: DERECHO INTERNACIONAL
ISBN: 9780102955071
Format: PDF, ePub, Mobi
Download Now
Approximately 580,000 adults in England currently have the disease with a further 26,000 new cases diagnosed each year. Rheumatoid arthritis costs the NHS an estimated £560 million annually and the estimated cost to the economy of sick leave and work-related disability for people with rheumatoid arthritis is £1.8 billion a year. The NHS does not consistently provide support for people with the disease to remain in, or get back into, work, with a lack of local links between the NHS and Jobcentre Plus services. Early diagnosis is the key to the successful treatment of rheumatoid arthritis but public awareness of the disease is low. People often delay seeking medical help from their GP, the disease is difficult to diagnose and requires specialist knowledge; and few GPs have the specialist expertise required to diagnose rheumatoid. The average length of time from symptom onset to treatment is nine months, compared to the clinically recommended period of three months, and this has not improved in the past five years. There is inconsistent coordination of the roles and activities of staff in different parts of the NHS: for example between GPs and hospital specialists. Furthermore, many patients do not have sufficient access to psychological services even though depression is common for people with rheumatoid arthritis; and the provision of quick response appointments in the event of a flare up is inconsistent. Current services also do not always match the Government's vision of a "systematic patient-centred approach" and the majority of PCTs are not commissioning as effectively as they could as they do not know the numbers of people in their area with rheumatoid arthritis.

Pharmaceutical Policy in Countries with Developing Healthcare Systems

Author: Zaheer-Ud-Din Babar
Publisher: Springer
ISBN: 3319516736
Format: PDF, Mobi
Download Now
A comprehensive and granular insight into the challenges of promoting rational medicine, this book serves as an essential resource for health policy makers and researchers interested in national medicines policies. Country-specific chapters have a common format, beginning with an overview of the health system and regulatory and policy environments, before discussing the difficulties in maintaining a medicines supply system, challenges in ensuring access to affordable medicines and issues impacting on rational medicine use. Numerous case studies are also used to highlight key issues and each chapter concludes with country-specific solutions to the issues raised. Written by highly regarded academics, the book includes countries in Africa, Asia, Europe, the Middle East and South America.